Aidoc

Aidoc is an enterprise clinical AI operating system that analyzes medical images in real time to flag acute findings, with 30+ FDA clearances and broad hospital deployment.

Aidoc provides an enterprise clinical AI operating system (aiOS) that runs a portfolio of algorithms analyzing CT scans, MRIs, and X-rays for time-critical findings such as pulmonary embolism, intracranial hemorrhage, and other acute or incidental conditions. By flagging suspected cases and helping prioritize worklists, it aims to speed diagnosis, triage, and downstream care coordination while returning capacity to radiologists. In 2026 Aidoc secured FDA clearance for a comprehensive healthcare foundation model and received Breakthrough Device Designation for First Read, AI that drafts preliminary radiology report text, extending the platform from detection toward what the company calls agentic radiology. It received 11 new indications at once in early 2026, bringing its total to more than 30 FDA clearances. Deployed across nearly 2,000 hospitals and having analyzed over 120 million patient cases, Aidoc is one of the most established clinical AI vendors. It integrates into existing PACS and radiology workflows and is backed by substantial venture funding, including a $150 million raise to advance AI in clinical decision-making.